# Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

> **NCT01016808** · PHASE3 · COMPLETED · sponsor: **QRxPharma Inc.** · enrollment: 522 (actual)

## Conditions studied

- Moderate to Severe Postoperative Pain

## Interventions

- **DRUG:** Q8003
- **DRUG:** Morphine sulfate
- **DRUG:** Oxycodone HCl

## Key facts

- **NCT ID:** NCT01016808
- **Lead sponsor:** QRxPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 522 (ACTUAL)
- **Last updated:** 2012-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016808, "Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01016808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*